loperamide has been researched along with mannitol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Buéno, L; Fioramonti, J; Hachet, T; Théodorou, V | 1 |
| Ahsan, MA; Ilundain, A; Naftalin, RJ; Sandhu, BK; Smith, PM | 1 |
| Costigan, C; Cox, EF; Garsed, KC; Gowland, PA; Hoad, CL; Marciani, L; Napolitano, A; Placidi, E; Pritchard, SE; Spiller, RC | 1 |
1 review(s) available for loperamide and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for loperamide and mannitol
| Article | Year |
|---|---|
The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea.
Topics: Adult; Antidiarrheals; Antifoaming Agents; Body Water; Cross-Over Studies; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Motility; Humans; Intestinal Absorption; Intestine, Small; Loperamide; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Simethicone; Young Adult | 2012 |
5 other study(ies) available for loperamide and mannitol
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Absorptive and motor components of the antidiarrhoeal action of loperamide: an in vivo study in pigs.
Topics: Animals; Colon; Diarrhea; Digestion; Gastrointestinal Motility; Gastrointestinal Transit; Intestinal Absorption; Loperamide; Mannitol; Swine; Water | 1991 |
Effects of theophylline, choleragen and loperamide on rabbit ileal fluid and electrolyte transport in vitro.
Topics: Animals; Body Fluids; Bromides; Chlorides; Cholera Toxin; Electrolytes; Ileum; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Loperamide; Male; Mannitol; Osmolar Concentration; Piperidines; Rabbits; Theophylline | 1987 |